Green Nail in a Patient With Psoriasis Receiving Deucravacitinib

Yoshihito Mima, Tsutomu Ohtsuka, Yuta Norimatsu · 2024

Read Green Nail in a Patient With Psoriasis Receiving Deucravacitinib by Yoshihito Mima, Tsutomu Ohtsuka, Yuta Norimatsu (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11739536.txt.

Description

Yoshihito Mima, Tsutomu Ohtsuka, and Yuta Norimatsu report a green nail in a man taking a psoriasis drug, in a case report published in twenty twenty-four. Green nail usually comes from a common bacterium and favors damaged nails, psoriatic nails, or hands kept wet. The drug, deucravacitinib, blocks a signaling enzyme and clears psoriasis well.

The patient, a man of seventy-two, developed the green nail four months into treatment. His nails had shown no psoriasis before the drug began, so the team suspects the drug played a part. They trace a possible route: the blocked enzyme carries signals for a protein that helps fight this bacterium. No earlier case tied the drug to green nail. The report asks clinicians to watch for it.

Catalog record

CREATORYoshihito Mima, Tsutomu Ohtsuka, Yuta Norimatsu
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE11 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11739536

Browse the full library · About the Tower of Babel